FN2 Earnings Intelligence

Zimmer Biomet Holdings, Inc. analyst ratings

Zimmer Biomet Holdings, Inc. (ZBH) analyst consensus, price targets, and firm-level rating history from FN2 Research.

Analyst Consensus ?

ConsensusHold42 ratings
Bullish1740.5%
Neutral2252.4%
Bearish37.1%

Analyst 52W Price Targets

$94.96Previous close
$83Low
$118.93Average
$180High

Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
BMO Capital Market Perform OutperformDowngradeJul 9, 2026
Evercore ISI Group Outperform OutperformMaintainJul 6, 2026
Citigroup Neutral NeutralMaintainMay 28, 2026
Wells Fargo Equal Weight Equal WeightMaintainApr 29, 2026
Truist Securities Hold HoldMaintainApr 29, 2026
Stifel Buy BuyMaintainApr 29, 2026
JP Morgan Neutral NeutralMaintainApr 29, 2026
Citizens Market Outperform Market OutperformMaintainApr 29, 2026
Show 34 more rating actions

Named analyst price targets

Upside is calculated against the persisted previous close $94.96. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSPatrick Wood$115$92.07 +21.1%Jul 28, 2026
BMO CapitalAnalyst unavailable$95$87.56 +0.0%Jul 8, 2026
Truist FinancialAnalyst unavailable$92$80.8 -3.1%Apr 29, 2026
Canaccord GenuityAnalyst unavailable$83$82.8 -12.6%Apr 29, 2026
Stifel NicolausRick Wise$105$82.8 +10.6%Apr 29, 2026
Robert W. BairdAnalyst unavailable$92$82.8 -3.1%Apr 29, 2026
BarclaysMatt Miksic$94$82.8 -1.0%Apr 29, 2026
BarclaysMatt Miksic$100$96.69 +5.3%Feb 12, 2026
UBSAnalyst unavailable$89$93.69 -6.3%Feb 11, 2026
UBSAnalyst unavailable$86$85.27 -9.4%Jan 28, 2026
See 57 more

Track every rating change on ZBH the moment it posts. Free to start.

Start free